- recruitingHuman Pharmacology (Phase I)- Other
ADP-A2M4CD8 in advanced cancers
This early-stage clinical trial tests an experimental cell therapy called ADP-A2M4CD8 for adults with advanced solid cancers, including lung, bladder, and ovarian cancer. Researchers want to find out the safest dose, understand any side effects, and see if this new treatment can help shrink tumours.
Spain - active not recruitingPHASE3
Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE)
This study is looking at two new drugs, durvalumab and tremelimumab, for advanced lung cancer. It compares them to standard chemotherapy. Researchers want to see if the new combination helps people live longer and is safe as a first treatment for this type of cancer.
United States · Argentina · Brazil